The technology landscape has reached an exciting milestone with the official patent recognition of a groundbreaking medical device that aims to revolutionize cognitive wellness through sleep optimization and active neuromodulation. This new system, patented under US Patent No. 12,649,043 for a “Sleep performance system and method of use,” was successfully filed by NeuroGeneces, Inc., a pioneering neurotechnology company dedicated to utilizing sleep science as a gateway to long-term brain health and preserving cognitive function.
In a thrilling announcement for the local biotechnology sector, this incredible invention has officially won the New Mexico State Patent of the Month for July 2026. The state selection committee honored this technology due to its incredible potential to combat age-related neurodegeneration and its collaborative history with the University of New Mexico, where pivotal clinical pilot studies were conducted. By celebrating this patent, the state recognizes a monumental shift away from traditional, bulky clinical sleep labs toward comfortable, home-based health monitors that actively improve memory retention, stress resilience, and emotional regulation.
Why the Sleep Performance System is So Innovative
The core innovation of the system lies in its ability to transition from passive monitoring to active, real-time sleep enhancement. Traditional consumer wearables merely record sleep duration and basic movement, but the NeuroGeneces system incorporates advanced electroencephalography (EEG) electrodes to actively measure a user’s brain activity during sleep. A sophisticated on-board processor then quantifies the quality of slow-wave sleep by calculating unique sleep performance and brain fitness scores. Most impressively, the brain fitness metric is derived from a meticulous weighting of total deep sleep, the longest continuous deep sleep stretch, and deep sleep strength, which is calculated using the root mean square (RMS) of slow-wave sleep amplitudes.
Once these specific neurological thresholds are established, the system delivers closed-loop sensory stimulation, such as precisely timed audio pulses, visual cues, or subtle cranial electrical stimulation, directly during the slow-wave sleep cycle. Acting like an audio pacemaker for the brain, this stimulation synchronizes with the brain’s natural frequencies to amplify slow oscillations. These oscillations are the exact brainwaves responsible for transferring memories from short-term storage in the hippocampus to long-term storage in the neocortex, making the system a powerful tool for enhancing cognitive performance and promoting healthy aging.
Applying Practical Applications for the US R&D Tax Credit
The practical applications and ongoing engineering required to bring this patented sleep performance system to commercial viability provide a robust pathway for companies to claim the United States Research and Development (R&D) Tax Credit under Internal Revenue Code Section 41. To qualify, a company’s activities must pass a rigid four-part test: they must serve a qualified purpose, eliminate technical uncertainty, involve a process of experimentation, and rely on hard science. The technical challenges involved in designing a flexible, low-profile EEG headband form factor to maximize consumer comfort while maintaining high signal-to-noise ratios represent clear technical uncertainties. Furthermore, the iterative programming, machine learning training, and testing of deep learning algorithms to reliably detect slow-wave sleep and deliver synchronized audio stimulation in real-time require an extensive process of experimentation. By documenting the employee wages, independent contractor costs, and raw supply expenses tied directly to these biomedical and software engineering workflows, businesses can successfully claim substantial tax credits to fund their continued neurotech innovations.
